๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Neuroblastoma
Clinical trial register · China

Neuroblastoma Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 7 Beijing 3 Chengdu 2 Guanzhou 1 Hangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou7 Beijing3 Chengdu2 Guanzhou1 Hangzhou1
All 9 locations
Target enrolment
to

Neuroblastoma trials in China

16 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
NCT04637503Neuroblastoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2026-12-31
Not yet open
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
NCT07090538Neuroblastoma
Chinese PLA General Hospital
Phase EARLY_PHASE1
10
Beijing
2025-08-01
Recruiting
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
NCT07067346Neuroblastoma
Sichuan University
Phase EARLY_PHASE1
10
Chengdu
2025-07-18
Recruiting
Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
NCT06933394Neuroblastoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
92
Guangzhou
2025-05-01
Recruiting
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
NCT06852807Neuroblastoma
First Affiliated Hospital of Zhejiang University
Observational
200
Hangzhou
2025-02-04
Recruiting
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
NCT07195500Neuroblastoma, Pheochromocytoma, Paraganglioma
Nanjing First Hospital, Nanjing Medical University
Observational
30
Nanjing
2024-12-25
Recruiting
A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
NCT06684639Neuroblastoma
The General Hospital of Western Theater Command
Phase EARLY_PHASE1
30
Chengdu
2024-12-01
Recruiting
Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
NCT06631391Neuroblastoma
Sun Yat-sen University
Phase 1
30
Guangzhou
2024-11-01
Recruiting
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
NCT06818916Delayed Platelet Engraftment, Neuroblastoma, Autologous Hematopoietic Stem Cell Transplantation
Beijing Children's Hospital
Not applicable
30
Beijing
2024-06-30
Recruiting
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
NCT06574698Neuroblastoma, GD2 Antibody (Naxitamab)
Guangzhou Women and Children's Medical Center
Observational
64
Guanzhou
2024-05-06
Recruiting
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
NCT06013618Neuroblastoma
Sun Yat-Sen University Cancer Center
Phase 2
120
Guangzhou
2023-06-19
Recruiting
APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors
NCT05701306Neuroblastoma, Solid Tumor
Ascentage Pharma Group Inc.
Phase 1/2
100
Guangzhou, Wuhan, Tianjin
2023-02-28
Not yet open
Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma
NCT05303727Neuroblastoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
64
Guangzhou
2022-08
Recruiting
Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
NCT07516678Neuroblastoma
Sun Yat-sen University
Observational
200
Guangzhou
2022-01-01
Recruiting
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
NCT05069220Neuroendocrine Tumor, Neuroblastoma, Pheochromocytoma, Paraganglioma
Peking Union Medical College Hospital
Phase EARLY_PHASE1
150
Beijing
2021-09-01
Active, closed
Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma
NCT03503864Neuroblastoma
Yang Li
Phase 2
80
Guangzhou
2017-06-12
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/neuroblastoma

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies listing the condition Neuroblastoma.

How many Neuroblastoma trials are recruiting in China?

12 of the 16 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Neuroblastoma), 16 studies
PhaseStudiesRecruitingShare
Observational4425%
Phase 24225%
Phase EARLY_PHASE14325%
Phase 1/22112.5%
Not applicable116.3%
Phase 1116.3%

Most active sponsors

Lead sponsors with the most studies (Neuroblastoma)
Lead sponsorStudiesRecruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University21
Sun Yat-sen University22
Ascentage Pharma Group Inc.11
Beijing Children's Hospital11
Chinese PLA General Hospital10
First Affiliated Hospital of Zhejiang University11
Guangzhou Women and Children's Medical Center11
Nanjing First Hospital, Nanjing Medical University11
Peking Union Medical College Hospital11
Shenzhen Geno-Immune Medical Institute10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.